TrialClinical transplantation2026

Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients-Results From Two Randomized Controlled Trials.

Klaus Murbraech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.